{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:32:40Z","timestamp":1791549160778,"version":"4.3.4"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Griscelli syndrome type 2 (GS-2) is a rare congenital immune dysfunction characterized by partial albinism and recurrent episodes of hemophagocytic lymphohistiocytosis (HLH). It is caused by a variant in the gene encoding Rab27a leading to a degranulation defect in melanocytes, natural killer (NK)- and T cells. Prognosis of patients with GS-2 is limited by repetitive episodes of life-threatening HLH with onset in early childhood. The only curative treatment is an allogeneic hematopoietic stem cell transplantation (HSCT). Here, we report on an 18 year old female patient with a homozygous missense p.Arg50Glnfs*35 variant in exon 2 of <jats:italic>RAB27A<\/jats:italic> who presented with an exceptionally late onset of severe HLH. Her phenotypically inapparent albinism complicated to correctly diagnose GS-2. Immune function assays confirmed a T- and NK cell degranulation deficiency characteristic for patients with primary HLH, while microscopic hair analysis revealed melanin clumps secondary to melanocyte functional impairment. To understand why disease onset occurred unusually late in this patient, we investigated the patient\u2019s T cell and polymorphonuclear neutrophil (PMN) function in more detail. We could show that intracellular granzyme B storage in cytotoxic T cells was increased compared to healthy donors and that the patient\u2019s T cells maintained some degranulation activity. Both, antigen-specific cytotoxic response and proliferation capacity of the patient\u2019s T cells were preserved. We demonstrate for the first time that also PMN degranulation, assessed as stimulation-induced CD66b and CD11b cell membrane expression, is dysfunctional in patients with Rab27a deficiency-associated primary HLH. The patient was treated with steroids and cyclosporine A for immunosuppression to control the HLH. After two severe episodes within only a few months, she eventually received an allogeneic HSCT and has not experienced further HLH episodes for now more than 3 years after the HSCT procedure. This case should raise awareness for the possibility of initial manifestation of primary, genetically-determined HLH even in adult patients.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1604460","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:29:12Z","timestamp":1754544552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism"],"prefix":"10.3389","volume":"16","author":[{"given":"Johanna","family":"Rausch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Liebh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagmur","family":"B\u00fclb\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edite","family":"Antunes Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Jan","family":"Legscha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Butsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kriege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Clara","family":"Lichtenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"La Ros\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Philipp","family":"Radsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Theobald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Echchannaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Munder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0002-9343(78)90858-6","article-title":"A syndrome associating partial albinism and immunodeficiency","volume":"65","author":"Griscelli","year":"1978","journal-title":"Am J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/76024","article-title":"Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome","volume":"25","author":"M\u00e9nasch\u00e9","year":"2000","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jb\/mvi002","article-title":"Versatile role of Rab27 in membrane trafficking: focus on the Rab27 effector families","volume":"137","author":"Fukuda","year":"2005","journal-title":"J Biochem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.152.4.843","article-title":"Rab27a: A key to melanosome transport in human melanocytes","volume":"152","author":"Bahadoran","year":"2001","journal-title":"J Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612977","article-title":"Griscelli syndrome type 2 sine albinism: unraveling differential RAB27A effector engagement","volume":"11","author":"Ohishi","year":"2020","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaci.2015.12.1337","article-title":"A novel Rab27a mutation binds melanophilin, but not Munc13-4, causing immunodeficiency without albinism","volume":"138","author":"Netter","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jaci.2018.02.031","article-title":"A RAB27A 5\u2032 untranslated region structural variant associated with late-onset hemophagocytic lymphohistiocytosis and normal pigmentation","volume":"142","author":"Tesi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jaci.2014.08.039","article-title":"Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13\u20134 binding","volume":"135","author":"Cetica","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-10-0923","article-title":"Munc13\u20134 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells","volume":"16","author":"Neeft","year":"2005","journal-title":"MBoC"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01154","article-title":"Alternative UNC13D promoter encodes a functional munc13\u20134 isoform predominantly expressed in lymphocytes and platelets","volume":"11","author":"Galgano","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140964","article-title":"Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time","volume":"212","author":"Jenkins","year":"2015","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.152.4.825","article-title":"Rab27a is required for regulated secretion in cytotoxic T lymphocytes","volume":"152","author":"Stinchcombe","year":"2001","journal-title":"J Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.177","article-title":"Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis","volume":"2015","author":"Allen","year":"2015","journal-title":"Hematology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2007.05.001","article-title":"Hemophagocytic syndromes","volume":"21","author":"Janka","year":"2007","journal-title":"Blood Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2016.00047\/abstract","article-title":"Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment","volume":"4","author":"Ishii","year":"2016","journal-title":"Front Pediatr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3201\/eid0606.000608","article-title":"Hemophagocytic syndromes and infection","volume":"6","author":"Fisman","year":"2000","journal-title":"Emerging Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1097\/00043426-199302000-00012","article-title":"Hypercytokinemia in hemophagocytic syndrome","volume":"15","author":"Fujiwara","year":"1993","journal-title":"J Pediatr Hematology\/Oncology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24669","article-title":"The diagnostic importance of multiple cytokines in adult hemophagocytic lymphohistiocytosis","volume":"37","author":"Jin","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.605","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis and treatment","volume":"2013","author":"Janka","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2284-9","article-title":"Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2)","volume":"94","author":"Henkes","year":"2015","journal-title":"Ann Hematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016045026204","article-title":"Griscelli disease: genotype\u2013phenotype correlation in an array of clinical heterogeneity","volume":"22","author":"Sanal","year":"2002","journal-title":"J Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20274","article-title":"Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses ofPRF1, UNC13D, STX11, andRAB27A","volume":"27","author":"Stadt","year":"2006","journal-title":"Hum Mutat"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001846","article-title":"\u0394133p53\u03b1 enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity","volume":"9","author":"Legscha","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.617699","article-title":"Inhibition of arginase 1 liberates potent T cell immunostimulatory activity of human neutrophil granulocytes","volume":"11","author":"Vonwirth","year":"2021","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.11.006","article-title":"A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo","volume":"27","author":"Echchannaoui","year":"2019","journal-title":"Mol Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M500143-MCP200","article-title":"Proteomic analysis of human neutrophil granules*S","volume":"4","author":"Lominadze","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20060950","article-title":"Rab27a is a key component of the secretory machinery of azurophilic granules in granulocytes","volume":"402","author":"Munaf\u00f3","year":"2007","journal-title":"Biochem J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.3793","article-title":"Rab27a regulates exocytosis of tertiary and specific granules in human neutrophils","volume":"181","author":"Herrero-Turri\u00f3n","year":"2008","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02409-18","article-title":"Antifungal drugs influence neutrophil effector functions","volume":"63","author":"Ries","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"B34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.11604\/pamj.2018.29.75.12353","article-title":"Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature","volume":"29","author":"Sefsafi","year":"2018","journal-title":"Pan Afr Med J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/08880010701533793","article-title":"Griscelli Syndrome: A case report","volume":"24","author":"Mehdizadeh","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/qjmed\/hcz144","article-title":"Griscelli syndrome type 2","volume":"113","author":"Gailson","year":"2020","journal-title":"QJM: Int J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.029389","article-title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases","volume":"95","author":"Rohr","year":"2010","journal-title":"Haematologica"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.682934","article-title":"Case report: hemophagocytic lymphohistiocytosis and non-tuberculous mycobacteriosis caused by a novel GATA2 variant","volume":"12","author":"Mika","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01315-4","article-title":"Novel RAB27A variant associated with late-onset hemophagocytic lymphohistiocytosis alters effector protein binding","volume":"42","author":"Zondag","year":"2022","journal-title":"J Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121233","article-title":"Reaching the threshold: A multilayer pathogenesis of macrophage activation syndrome","volume":"40","author":"Strippoli","year":"2013","journal-title":"J Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.18502\/ijaai.v21i4.10297","article-title":"Neonatal onset of hemophagocytic lymphohistiocytosis due to prenatal varicella-zoster infection in a neonate with griscelli syndrome type 2","volume":"21","author":"Nodehi","year":"2022","journal-title":"Iranian J Allergy Asthma Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61829","article-title":"A founder RAB27A variant causes Griscelli syndrome type 2 with phenotypic heterogeneity in Qatari families","volume":"182","author":"Al-Sulaiman","year":"2020","journal-title":"Am J Med Genet Part A"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062447","article-title":"Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis","volume":"204","author":"Crozat","year":"2007","journal-title":"J Exp Med"},{"key":"B44","article-title":"Secondary hemophagocytic lymphohistiocytosis in post-COVID-19 patients: A report of two cases","volume":"13","author":"Kalita","year":"2021","journal-title":"Cureus"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-021-00452-w","article-title":"Hemophagocytic lymphohistiocytosis, a new cause of death during \u2018post-acute COVID-19 syndrome?\u2019 A case report","volume":"14","author":"Naous","year":"2021","journal-title":"J Hematopathol"},{"key":"B46","article-title":"Secondary hemophagocytic lymphohistiocytosis in a post-COVID-19 patient","volume":"14","author":"Bandaru","year":"2022","journal-title":"Cureus"},{"key":"B47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10875-024-01842-2","article-title":"Griscelli syndrome type 2: comprehensive analysis of 149 new and previously described patients with RAB27A deficiency","volume":"45","author":"Maimaris","year":"2024","journal-title":"J Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.152.4.835","article-title":"Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice","volume":"152","author":"Haddad","year":"2001","journal-title":"J Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00072","article-title":"Elevated granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis","volume":"4","author":"Mellor-Heineke","year":"2013","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1189\/jlb.3AB0416-189RR","article-title":"Rab27a regulates GM-CSF-dependent priming of neutrophil exocytosis","volume":"101","author":"Ramadass","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jpeds.2011.11.046","article-title":"Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children","volume":"160","author":"Xu","year":"2012","journal-title":"J Pediatrics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001333","article-title":"Calming the storm in HLH","volume":"134","author":"Zinter","year":"2019","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850443","article-title":"Simple evaluation of clinical situation and subtypes of pediatric hemophagocytic lymphohistiocytosis by cytokine patterns","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-374199","article-title":"A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes","volume":"119","author":"Bryceson","year":"2012","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1604460\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:29:14Z","timestamp":1754544554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1604460\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2025.1604460"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1604460","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"article-number":"1604460"}}